logo

For the Inventor, By the Inventor

Copenhagen, Denmark

Christian Poulsen

This inventor holds 9 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Novo Nordisk A/s, N.v. Adb Ttv Technologies Sa. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Poulsen. Retrieved from https://idiyas.com/inventor/christian-poulsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 61(Granted Patents)


Location History:

  • København K, DK (2015)
  • Copenhagen, DK (2004 - 2019)
  • Ballerup, DK (2024)

Company Filing History:

goldMedal8 out of 1,802 
 
Novo Nordisk A/s
 patents
silverMedal1 out of 1 
 
N.v. Adb Ttv Technologies Sa
 patent

Years Active: 2004-2026

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12741014 - Pharmaceutical formulations (2026-09-22),
2. 12741013 - Pharmaceutical formulations (2026-09-22),
3. 12527844 - Pharmaceutical formulations (2026-01-20),
4. 12077561 - CNP compounds (2024-09-03),
5. 10174082 - Amylin and calcitonin receptor agonist (2019-01-08),
6. 9034818 - Pharmaceutical formulations comprising an insulin derivative (2015-05-19),
7. 8937042 - Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide (2015-01-20),
8. 8097584 - Stabilized formulations of insulin that comprise ethylenediamine (2012-01-17),
9. 6744693 - Lighting fixture (2004-06-01),

Title: Christian Poulsen: Innovator in Pharmaceutical Compounds

Introduction

Christian Poulsen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work primarily focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the development of C-type natriuretic peptide (CNP) compounds. This application relates to new CNP compounds, pharmaceutical compositions comprising these compounds, and their use as medicaments. Another significant invention is the amylin and calcitonin receptor agonist. This invention pertains to peptides comprising a specific amino acid sequence and their pharmaceutical compositions, which are also intended for use as medicaments.

Career Highlights

Christian Poulsen has worked with prominent companies in the pharmaceutical industry, including Novo Nordisk A/S and N.V. Adb Ttv Technologies S.A. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Throughout his career, Poulsen has collaborated with various professionals, including Dorte Bjerre Steensgaard and Thomas Brockmann. These collaborations have likely enriched his research and development efforts.

Conclusion

Christian Poulsen's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a dedication to creating effective therapeutic solutions that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…